Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

The response of psychotic symptoms in a patient with resistant schizophrenia under treatment of high-dose risperidone long-acting injection.

Hou YC, Lai CH.

J Neuropsychiatry Clin Neurosci. 2014 Summer;26(3):E16-7. doi: 10.1176/appi.neuropsych.13070150. No abstract available.

PMID:
25093771
2.

Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.

Lasser RA, Bossie CA, Zhu Y, Gharabawi G, Eerdekens M, Davidson M.

Int J Geriatr Psychiatry. 2004 Sep;19(9):898-905.

PMID:
15352149
3.

A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder.

Simpson GM, Mahmoud RA, Lasser RA, Kujawa M, Bossie CA, Turkoz I, Rodriguez S, Gharabawi GM.

J Clin Psychiatry. 2006 Aug;67(8):1194-203.

PMID:
16965196
4.

Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders.

Lai YC, Huang MC, Chen CH, Tsai CJ, Pan CH, Chiu CC.

Psychiatry Clin Neurosci. 2009 Aug;63(4):440-8. doi: 10.1111/j.1440-1819.2009.01977.x. Epub 2009 Apr 27.

5.
6.

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.

Davidson M, Harvey PD, Vervarcke J, Gagiano CA, De Hooge JD, Bray G, Dose M, Barak Y, Haushofer M.

Int J Geriatr Psychiatry. 2000 Jun;15(6):506-14.

PMID:
10861916
7.

Risperidone versus placebo for schizophrenia.

Rattehalli RD, Jayaram MB, Smith M.

Schizophr Bull. 2010 May;36(3):448-9. doi: 10.1093/schbul/sbq030. Epub 2010 Apr 5. No abstract available.

8.

[Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].

Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC.

Encephale. 2007 Dec;33(6):973-81. doi: 10.1016/j.encep.2006.07.003. Epub 2007 Sep 4. French.

PMID:
18789790
9.

Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.

Keck PE Jr, Wilson DR, Strakowski SM, McElroy SL, Kizer DL, Balistreri TM, Holtman HM, DePriest M.

J Clin Psychiatry. 1995 Oct;56(10):466-70.

PMID:
7559373
10.

Long-acting injectable risperidone as an option in first-episode psychosis.

Covell NH.

Evid Based Ment Health. 2016 May;19(2):e8. doi: 10.1136/eb-2015-102207. Epub 2016 Apr 12. No abstract available.

PMID:
27073212
11.

Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone.

Gharabawi GM, Lasser RA, Bossie CA, Zhu Y, Amador X.

Int Clin Psychopharmacol. 2006 Jul;21(4):233-40.

PMID:
16687995
12.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
13.

Treatment with risperidone of an acute psychotic episode in a patient with AIDS.

Zilikis N, Nimatoudis I, Kiosses V, Ierodiakonou C.

Gen Hosp Psychiatry. 1998 Nov;20(6):384-5. No abstract available.

PMID:
9854654
14.

MDR1 gene polymorphisms and response to acute risperidone treatment.

Kastelic M, Koprivsek J, Plesnicar BK, Serretti A, Mandelli L, Locatelli I, Grabnar I, Dolzan V.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):387-92. doi: 10.1016/j.pnpbp.2010.01.005. Epub 2010 Jan 11.

PMID:
20060871
15.

Risperidone in the treatment of psychosis and concomitant buccolinguomasticatory dyskinesia in the elderly.

Koponen HJ.

Int J Geriatr Psychiatry. 1997 Mar;12(3):412-3. No abstract available.

PMID:
9152730
16.

Risperidone in the treatment of psychotic depression.

Miodownik C, Lerner V.

Clin Neuropharmacol. 2000 Nov-Dec;23(6):335-7.

PMID:
11575868
17.

Risperidone and Parkinson's disease.

Factor SA, Molho ES, Friedman JH.

Mov Disord. 2002 Jan;17(1):221-2. No abstract available.

PMID:
11835472
18.

Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia.

Barnett PG, Scott JY, Krystal JH, Rosenheck RA; CSP 555 Research Group.

J Clin Psychiatry. 2012 May;73(5):696-702. doi: 10.4088/JCP.11m07070.

PMID:
22697193
19.

Safety and efficacy of risperidone in substance abusers with psychosis.

Albanese MJ.

Am J Addict. 2001 Spring;10(2):190-1. No abstract available.

PMID:
11444160
20.

Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.

Parellada E, Andrezina R, Milanova V, Glue P, Masiak M, Turner MS, Medori R, Gaebel W.

J Psychopharmacol. 2005 Sep;19(5 Suppl):5-14.

PMID:
16144781

Supplemental Content

Support Center